| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 09/23/2014 | US8841309 Substituted pyrazines and their use in the treatment of disease |
| 09/23/2014 | US8841308 Pyrazin-2-amines useful as inhibitors of ATR kinase |
| 09/23/2014 | US8841307 Method of using diketopiperazines and composition containing them |
| 09/23/2014 | US8841306 Antimicrobials |
| 09/23/2014 | US8841305 Activators of the human pyruvate kinase M2 receptor |
| 09/23/2014 | US8841304 Pyrrolopyridines as kinase inhibitors |
| 09/23/2014 | US8841303 Melt-processed imatinib dosage form |
| 09/23/2014 | US8841302 HCV inhibitor and therapeutic agent combinations |
| 09/23/2014 | US8841301 Selective NR2B antagonists |
| 09/23/2014 | US8841300 Treatment for Parkinson's disease—combination high dose serotonergic synaptic reuptake inhibitor with phosphodiesterase inhibitor |
| 09/23/2014 | US8841299 Substituted pyrrolo[1,2-a]pyrazines as tankyrase inhibitors |
| 09/23/2014 | US8841298 Substituted pyrano[2,3-B]pyrazines as herbicides |
| 09/23/2014 | US8841297 Phenylimidazole derivative as PDE10A enzyme inhibitor |
| 09/23/2014 | US8841295 5-lipoxygenase-activating protein (FLAP) inhibitors |
| 09/23/2014 | US8841294 Active ingredient combinations having insecticidal and acaricidal properties |
| 09/23/2014 | US8841293 Tetrahydropyrrolothiazine compounds |
| 09/23/2014 | US8841292 Induced hypothermia |
| 09/23/2014 | US8841291 Selective hydroxamic acid based MMP-12 and MMP-13 inhibitors |
| 09/23/2014 | US8841289 Heterocyclic derivatives |
| 09/23/2014 | US8841288 Quinolin-4 (1H)-one derivatives as inhibitors of phosphatidylinositol 3-kinases |
| 09/23/2014 | US8841286 Inhalable aztreonam lysinate formulation for treatment and prevention of pulmonary bacterial infections |
| 09/23/2014 | US8841285 Potent immunosuppressive agents, derivatives and uses |
| 09/23/2014 | US8841284 Compound having neurite-outgrowing activity |
| 09/23/2014 | US8841283 Methods for the preparation of drospirenone and intermediates thereof |
| 09/23/2014 | US8841281 Transition metal complexes of amino acids and related ligands and their use as catalysts, anti-microbials, and anti-cancer agents |
| 09/23/2014 | US8841279 Oligo-guluronate and galacturonate compositions |
| 09/23/2014 | US8841278 Antiviral compounds |
| 09/23/2014 | US8841277 Methods for treating non-small cell lung cancer using 5-azacytidine |
| 09/23/2014 | US8841276 Fulvene and fulvalene analogs and their use in treating cancers |
| 09/23/2014 | US8841275 2′-spiro-nucleosides and derivatives thereof useful for treating hepatitis C virus and dengue virus infections |
| 09/23/2014 | US8841270 Use of inhibitors of Zdhhc2 activity for modulation of adipogenesis |
| 09/23/2014 | US8841265 Composition comprising triterpene saponins and compounds with angeloyl functional group, methods for preparing same and uses thereof |
| 09/23/2014 | US8841264 Compositions |
| 09/23/2014 | US8841263 Macrocyclic compounds and methods of making and using the same |
| 09/23/2014 | US8841262 Agent for inhibiting peritoneal membrane thickening |
| 09/23/2014 | US8841261 Functional powdery product |
| 09/23/2014 | US8841258 Methods to accelerate tissue and wound healing rates and reduce swelling and scar formation |
| 09/23/2014 | US8841257 Inhibitors of STAT3 and uses thereof |
| 09/23/2014 | US8841256 P2X7: inhibition of epithelial cancers and papillomas |
| 09/23/2014 | US8841100 Use of methylsulfonylmethane (MSM) to modulate microbial activity |
| 09/23/2014 | US8841097 Process for producing unsaturated fatty acid-containing oils |
| 09/23/2014 | US8841067 NOL3 is a predictor of patient outcome |
| 09/23/2014 | US8840939 Vigna unguiculata seed extract and compositions containing same |
| 09/23/2014 | US8840938 Bioavailability enhancing composition |
| 09/23/2014 | US8840933 Method of treating neuronal injury by administering magnesium chloride and PEG |
| 09/23/2014 | US8840932 Antiseptic compositions and methods |
| 09/23/2014 | US8840931 Pharmaceutical compositions for dehydrating, atrophying and eliminating pathological tissues |
| 09/23/2014 | US8840928 Tamper-resistant pharmaceutical compositions of opioids and other drugs |
| 09/23/2014 | US8840924 Compositions and methods of making rapidly dissolving ionically masked formulations |
| 09/23/2014 | US8840923 Slow-release pharmaceutical formulation and process for its preparation |
| 09/23/2014 | US8840922 Transdermally absorbable donepezil-containing preparation |
| 09/23/2014 | US8840921 Patch production technology |
| 09/23/2014 | US8840912 Imidazole derivatives useful for controlling microbial growth |
| 09/23/2014 | US8840911 Moisturizing hand sanitizer |
| 09/23/2014 | US8840905 Use of neurotoxin therapy for treatment of urologic and related disorders |
| 09/23/2014 | US8840899 Use of mTOR inhibitors to enhance T cell immune responses |
| 09/23/2014 | US8840892 Method of administering antibiotic therapy for treating intracellular infectious diseases |
| 09/23/2014 | US8840883 Metallo-protein and tocotrienol (MP-T3) compositions with non-protein-type metal chelator and uses thereof |
| 09/23/2014 | US8840879 Conjugates of hydroxyalkyl starch and a protein |
| 09/23/2014 | US8840875 Anti-viral agents and compositions thereof |
| 09/23/2014 | US8840874 Vascular delivery systems |
| 09/23/2014 | US8840873 Method of treating second and third degree burns using oxidative reductive potential water solution |
| 09/23/2014 | US8840872 Ocular therapy using glucocorticoid derivatives selectively penetrating posterior segment tissues |
| 09/23/2014 | US8840867 Embolizing sclerosing hydrogel |
| 09/23/2014 | US8840865 Technetium- and rhenium-bis(heteroaryl) complexes and methods of use thereof |
| 09/23/2014 | CA2782347C Quinoline amide m1 receptor positive allosteric modulators |
| 09/23/2014 | CA2774264C Improved device and method for delivery of a medicament |
| 09/23/2014 | CA2758019C Imidaz0[1,2-a] pyridine-6-carboxamide derivatives, their use for the treatment of colon cancer and their method of manufacture |
| 09/23/2014 | CA2756811C Liposome composition of eribulin or its pharmacologically permissible salt |
| 09/23/2014 | CA2752527C Indole/benzimidazole compounds as mtor kinase inhibitors |
| 09/23/2014 | CA2752143C Delivery of nucleic acid-like compounds |
| 09/23/2014 | CA2725390C Use of a hdac inhibitor and a her-2 inhibitor in the treatment of breast cancer |
| 09/23/2014 | CA2718697C Extended release formulation containing a wax |
| 09/23/2014 | CA2696185C Use of taurolidine and derivatives thereof in the treatment of cancer by induction of apoptosis |
| 09/23/2014 | CA2675246C Compositions and methods of reducing side effects and toxicity of methotrexate when given as orotate derivatives |
| 09/23/2014 | CA2672261C Methods for treating cystic fibrosis or pneumonia with bacterial infection via pulmonary administration of fosfomycin |
| 09/23/2014 | CA2659050C Camptothecin derivatives with antitumor activity |
| 09/23/2014 | CA2658902C Camptothecin derivatives with antitumor activity |
| 09/23/2014 | CA2653206C Transporter-enhanced corticosteroid activity |
| 09/23/2014 | CA2651987C Piperidinyl derivatives as modulators of chemokine receptor activity |
| 09/23/2014 | CA2648537C Method for preparing 4-[17.beta.-methoxy-17.alpha.-methoxymethyl-3-oxoestra-4,9-dien-11.beta.-yl]benzaldehyde (e)-oxime (asoprisnil) |
| 09/23/2014 | CA2647417C Buprenorphine derivatives and uses thereof |
| 09/23/2014 | CA2631408C Composition having effect on treatment and prevention of dry eye syndrome |
| 09/23/2014 | CA2629738C Novel indolizine derivatives, method for preparing same and therapeutic compositions comprising same |
| 09/23/2014 | CA2628413C Prostaglandins and analogues as agents for lowering intraocular pressure |
| 09/23/2014 | CA2616222C Method for producing tiotropium salts comprising an esterification reaction of methylscopinium and a dithienyl derivative |
| 09/23/2014 | CA2612264C Heterocyclylaminoalkyl substituted benzimidazoles |
| 09/23/2014 | CA2611114C An entacapone-containing oral dosage form |
| 09/23/2014 | CA2610767C Tanaproget compositions containing ethinyl estradiol |
| 09/23/2014 | CA2609612C Use of huperzine to treat epilepsy |
| 09/23/2014 | CA2608977C Antifungal agents |
| 09/23/2014 | CA2608153C Thiazole derivatives for use as p13k modulators |
| 09/23/2014 | CA2602968C Crystals of morphinan derivative and process for producing the same |
| 09/23/2014 | CA2602121C Pharmaceutical composition and method using an antifungal arylamidine in combination |
| 09/23/2014 | CA2588908C Induction of neurogenesis and stem cell therapy in combination with copolymer 1 |
| 09/23/2014 | CA2584866C Mitotic kinesin inhibitors and methods of use thereof |
| 09/23/2014 | CA2582347C Novel benzimidazole derivatives useful as selective androgen receptor modulators (sarms) |
| 09/23/2014 | CA2575341C Trpv1 agonists, formulations containing them and uses thereof |
| 09/23/2014 | CA2551686C Stereoisomeric compounds and methods for the treatment of gastrointestinal and central nervous system disorders |
| 09/23/2014 | CA2548917C Combination of a sedative and a neurotransmitter modulator, and methods for improving sleep quality and treating depression |